Cargando…
hsa-miR-15a-5p inhibits colon cell carcinoma via targeting CCND1
Colon carcinoma is one of the most common cancers worldwide. Epidemiological studies have revealed that colon cancer is the third leading cause of cancer-related deaths, which is due to the increased incidence and mortality rates. However, the treatment strategies for colon cancer remain unsatisfact...
Autores principales: | Li, Zhipeng, Zhu, Zeyu, Wang, Yanjun, Wang, Ying, Li, Weibing, Wang, Zhigang, Zhou, Xinyuan, Bao, Yuhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404101/ https://www.ncbi.nlm.nih.gov/pubmed/34414457 http://dx.doi.org/10.3892/mmr.2021.12375 |
Ejemplares similares
-
Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development
por: Sun, Chengcao, et al.
Publicado: (2016) -
MiR-200c-3p aggravates gastric cell carcinoma via KLF6
por: Wang, Ying, et al.
Publicado: (2021) -
Hsa-miR-134 suppresses non-small cell lung cancer (NSCLC) development through down-regulation of CCND1
por: Sun, Cheng-Cao, et al.
Publicado: (2016) -
The Involvement of the hsa_circ_0088494-miR-876-3p-CTNNB1/CCND1 Axis in Carcinogenesis and Progression of Papillary Thyroid Carcinoma
por: Lou, Weiyang, et al.
Publicado: (2020) -
Differential expression of hsa-miR-221, hsa-miR-21, hsa-miR-135b, and hsa-miR-29c suggests a field effect in oral cancer
por: Lopes, Camile B., et al.
Publicado: (2018)